Vaccí contra el papil·lomavirus humà (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaccí contra el papil·lomavirus humà" in Catalan language version.

refsWebsite
Global rank Catalan rank
1st place
1st place
4th place
7th place
2nd place
6th place
218th place
281st place
3,011th place
2,879th place
1,684th place
1,053rd place
99th place
435th place
447th place
656th place
low place
low place
993rd place
372nd place
6,464th place
6,588th place
49th place
152nd place
4,901st place
71st place
low place
4,743rd place
low place
low place
low place
low place
34th place
147th place
low place
low place
low place
low place
low place
low place
68th place
49th place
195th place
155th place
low place
low place
222nd place
128th place
low place
9,136th place
low place
8,350th place
low place
low place
low place
low place
7th place
14th place
8,489th place
6,500th place
8th place
26th place
low place
low place
low place
low place
low place
low place
3,596th place
4,134th place
low place
low place
6,437th place
low place
low place
low place
low place
low place
low place
low place
8,245th place
low place
6,017th place
low place
70th place
159th place
79th place
267th place
low place
low place
216th place
204th place
low place
low place
low place
low place
low place
low place
low place
low place

about.com

cancer.about.com

ashastd.org

avert.org

bbc.co.uk

news.bbc.co.uk

biosfera.cat

bloomberg.com

cancer.gov

seer.cancer.gov

cancer.gov

cancerresearchuk.org

info.cancerresearchuk.org

cancerscreening.nhs.uk

cdc.gov

cervicalcanceraction.org

columbiatribune.com

doi.org

dx.doi.org

  • Dunne EF, Unger ER, Sternberg M, et al «Prevalence of HPV infection among females in the United States». JAMA : the journal of the American Medical Association, 297, 8, Febrer 2007, pàg. 813–9. DOI: 10.1001/jama.297.8.813. PMID: 17327523.
  • Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ «HPV-mediated cervical carcinogenesis: concepts and clinical implications.». J. Pathol., 208, 2, 2006, pàg. 152–64. DOI: 10.1002/path.1866. PMID: 16362994 [Consulta: 21 febrer 2008]. «cervical cancer is a rare complication of an hrHPV infection since most such infections are transient, not even giving rise to cervical lesions.»
  • McNeil C «Who invented the VLP cervical cancer vaccines?». Journal of the National Cancer Institute, 98, 7, abril 2006, pàg. 433. DOI: 10.1093/jnci/djj144. PMID: 16595773.
  • Roden RB, Ling M, Wu TC «Vaccination to prevent and treat cervical cancer». Human pathology, 35, 8, agost 2004, pàg. 971–82. DOI: 10.1016/j.humpath.2004.04.007. PMID: 15297964.
  • Lowy DR, Schiller JT «Prophylactic human papillomavirus vaccines». The Journal of clinical investigation, 116, 5, maig 2006, pàg. 1167–73. DOI: 10.1172/JCI28607. PMC: 1451224. PMID: 16670757.
  • D'Souza G, Kreimer AR, Viscidi R, et al «Case-control study of human papillomavirus and oropharyngeal cancer». The New England journal of medicine, 356, 19, maig 2007, pàg. 1944–56. DOI: 10.1056/NEJMoa065497. PMID: 17494927.
  • Winer RL, Hughes JP, Feng Q, et al «Condom use and the risk of genital human papillomavirus infection in young women». The New England journal of medicine, 354, 25, juny 2006, pàg. 2645–54. DOI: 10.1056/NEJMoa053284. PMID: 16790697.
  • Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ «Against which human papillomavirus types shall we vaccinate and screen? The international perspective.». Int J Cancer, 111, 21-02-2008, pàg. 278–85. DOI: 10.1002/ijc.20244. PMID: 15197783.
  • Harper DM, Franco EL, Wheeler CM, et al «Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial». Lancet, 367, 9518, abril 2006, pàg. 1247–55. DOI: 10.1016/S0140-6736(06)68439-0. PMID: 16631880.
  • Cutts FT, Franceschi S, Goldie S 'et al.' «Human papillomavirus and HPV vaccines: a review». Bull World Health Organ, 85, 9, 2007, pàg. 719–26. DOI: 10.2471/BLT.06.038414. PMID: 18026629.

europa.eu

emea.europa.eu

  • Comunicat de premsa de l'EMEA[Enllaç no actiu]  PDF (anglès)

family.org

fda.gov

frc.org

fskilkis.gr

gandul.info

gov.ns.ca

gov.on.ca

premier.gov.on.ca

health.gov.au

iatronet.gr

jiwh.org

kaisernetwork.org

lavanguardia.es

loc.gov

webarchive.loc.gov

medicalnewstoday.com

merck.com

merckpregnancyregistries.com

msd-korea.com

ncsl.org

newstandardnews.net

nih.gov

ncbi.nlm.nih.gov

  • Dunne EF, Unger ER, Sternberg M, et al «Prevalence of HPV infection among females in the United States». JAMA : the journal of the American Medical Association, 297, 8, Febrer 2007, pàg. 813–9. DOI: 10.1001/jama.297.8.813. PMID: 17327523.
  • Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ «HPV-mediated cervical carcinogenesis: concepts and clinical implications.». J. Pathol., 208, 2, 2006, pàg. 152–64. DOI: 10.1002/path.1866. PMID: 16362994 [Consulta: 21 febrer 2008]. «cervical cancer is a rare complication of an hrHPV infection since most such infections are transient, not even giving rise to cervical lesions.»
  • McNeil C «Who invented the VLP cervical cancer vaccines?». Journal of the National Cancer Institute, 98, 7, abril 2006, pàg. 433. DOI: 10.1093/jnci/djj144. PMID: 16595773.
  • Roden RB, Ling M, Wu TC «Vaccination to prevent and treat cervical cancer». Human pathology, 35, 8, agost 2004, pàg. 971–82. DOI: 10.1016/j.humpath.2004.04.007. PMID: 15297964.
  • Lowy DR, Schiller JT «Prophylactic human papillomavirus vaccines». The Journal of clinical investigation, 116, 5, maig 2006, pàg. 1167–73. DOI: 10.1172/JCI28607. PMC: 1451224. PMID: 16670757.
  • D'Souza G, Kreimer AR, Viscidi R, et al «Case-control study of human papillomavirus and oropharyngeal cancer». The New England journal of medicine, 356, 19, maig 2007, pàg. 1944–56. DOI: 10.1056/NEJMoa065497. PMID: 17494927.
  • Cottler L, Garvin EC, Callahan C «Condom use and the risk of HPV infection». The New England journal of medicine, 355, 13, setembre 2006, pàg. 1388–9; author reply 1389. PMID: 17014039.
  • Winer RL, Hughes JP, Feng Q, et al «Condom use and the risk of genital human papillomavirus infection in young women». The New England journal of medicine, 354, 25, juny 2006, pàg. 2645–54. DOI: 10.1056/NEJMoa053284. PMID: 16790697.
  • Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR «Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic». Sexually transmitted diseases, 31, 10, octubre 2004, pàg. 601–7. Arxivat de l'original el 2012-02-26. PMID: 15388997 [Consulta: 20 febrer 2009]. Arxivat 2012-02-26 a Wayback Machine.
  • Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ «Against which human papillomavirus types shall we vaccinate and screen? The international perspective.». Int J Cancer, 111, 21-02-2008, pàg. 278–85. DOI: 10.1002/ijc.20244. PMID: 15197783.
  • Harper DM, Franco EL, Wheeler CM, et al «Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial». Lancet, 367, 9518, abril 2006, pàg. 1247–55. DOI: 10.1016/S0140-6736(06)68439-0. PMID: 16631880.
  • Cutts FT, Franceschi S, Goldie S 'et al.' «Human papillomavirus and HPV vaccines: a review». Bull World Health Organ, 85, 9, 2007, pàg. 719–26. DOI: 10.2471/BLT.06.038414. PMID: 18026629.

nytimes.com

phac-aspc.gc.ca

plannedparenthood.org

  • Planned Parenthood Arxivat 2009-04-25 a Wayback Machine. (anglès)

reuters.com

scielosp.org

sciencedaily.com

service-public.fr

vaccinerx.com

washingtonpost.com

web.archive.org

who.int

wiley.com

www3.interscience.wiley.com

wkhealth.com

meta.wkhealth.com

womenshealthchannel.com

wsj.com

online.wsj.com

yourcancertoday.com